Detail
Customer Reviews
Generic name: Dengzhanxixin capsule
Chinese Pinyin: DengZhanXiXinJiaoNang
Product name: Haobang
Ingredients: The main ingredient of this product is Erigeron breviscapus.
Properties: This product is a capsule, the content is dark brown granules; the gas is slightly bitter.
Functions and indications: Promoting blood circulation and removing blood stasis, used for blood stasis type stroke and chest obstruction. Symptoms: chest pain, external pain, not red face, dark red tongue, dark purple or ecchymosis, narrow pulse string, astringent or congestion patient. Treat coronary heart disease, angina pectoris, cerebral thrombosis, paralysis caused by cerebral infarction, etc.
Specification: 0.18g*24 capsules/box
Usage and dosage: Orally, 2-3 capsules at a time, 3 times a day, or as directed by a doctor.
Adverse reactions: not yet clear
Taboo: Not yet clear
Note: Not yet clear
Drug interactions: Drug interactions may occur if used with other drugs at the same time. Please consult your physician or pharmacist for details.
Pharmacology and Toxicology: Unclear
Storage: sealed.
Packaging: Aluminum-plastic blister packaging. 12 tablets/plate*2 plates/box.
Validity period: 24 months
Executive standard: Standard for new drug conversion, Volume 63 WS3-179(Z-58)-2004(Z)
Approval number: National Medicine Standard Z53021653
Company Name: Yunnan Haobang Pharmaceutical Co., Ltd.
Enterprise Address: No.604 Xuefu Road, Kunming City
Chinese Pinyin: DengZhanXiXinJiaoNang
Product name: Haobang
Ingredients: The main ingredient of this product is Erigeron breviscapus.
Properties: This product is a capsule, the content is dark brown granules; the gas is slightly bitter.
Functions and indications: Promoting blood circulation and removing blood stasis, used for blood stasis type stroke and chest obstruction. Symptoms: chest pain, external pain, not red face, dark red tongue, dark purple or ecchymosis, narrow pulse string, astringent or congestion patient. Treat coronary heart disease, angina pectoris, cerebral thrombosis, paralysis caused by cerebral infarction, etc.
Specification: 0.18g*24 capsules/box
Usage and dosage: Orally, 2-3 capsules at a time, 3 times a day, or as directed by a doctor.
Adverse reactions: not yet clear
Taboo: Not yet clear
Note: Not yet clear
Drug interactions: Drug interactions may occur if used with other drugs at the same time. Please consult your physician or pharmacist for details.
Pharmacology and Toxicology: Unclear
Storage: sealed.
Packaging: Aluminum-plastic blister packaging. 12 tablets/plate*2 plates/box.
Validity period: 24 months
Executive standard: Standard for new drug conversion, Volume 63 WS3-179(Z-58)-2004(Z)
Approval number: National Medicine Standard Z53021653
Company Name: Yunnan Haobang Pharmaceutical Co., Ltd.
Enterprise Address: No.604 Xuefu Road, Kunming City